The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
2 reports and counting
Updated daily with latest market intelligence
Biotech
Zymergen
Zymergen raises $130M Series C at $560M valuation
Zymergen raises $130M in Series C at $560M valuation. Bio-based materials and molecule development...
Editorial Team
Dec 4, 2018
1 min read•$130M
Synthetic Biology
Zymergen
Zymergen transforms synthetic biology industry with $300M Series C at $3.2B valuation
Zymergen achieves $3.2B valuation through $300M Series C funding, establishing dominance in the synthetic biology market with innovative biomanufacturing platform for materials and chemicals.
Michael Chang
Aug 6, 2025
8 min read•$300M
Page 1
Showing 2 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.